RE:Company is a long shot2019champs wrote: Repurposed drugs with diluted share structure in biotech dont really do well. I bought in the 30 cent range and hold about 2000 shares, lets see what happens. I like companies like arch biopartners & immunoprecise alot more. I think these are 20 bagger potentials easily.
In regards to Immunoprecise, why did an insider pull out l.9 million dollars worth of shares in 3 consecutive days filed September l4th, 2020? That's definitely a red flag in my books.